* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Pharmacodynamics What the drug does to the body?
Pharmaceutical industry wikipedia , lookup
Discovery and development of beta-blockers wikipedia , lookup
Prescription costs wikipedia , lookup
5-HT2C receptor agonist wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Pharmacokinetics wikipedia , lookup
Discovery and development of antiandrogens wikipedia , lookup
Pharmacognosy wikipedia , lookup
5-HT3 antagonist wikipedia , lookup
NMDA receptor wikipedia , lookup
Drug discovery wikipedia , lookup
Drug design wikipedia , lookup
Toxicodynamics wikipedia , lookup
Discovery and development of angiotensin receptor blockers wikipedia , lookup
Cannabinoid receptor antagonist wikipedia , lookup
Drug interaction wikipedia , lookup
Nicotinic agonist wikipedia , lookup
Psychopharmacology wikipedia , lookup
NK1 receptor antagonist wikipedia , lookup
Pharmacology RHPT-365 Chapter 3: PHARMACODYNAMICS By Majid Ahmad Ganaie M. Pharm., Ph.D. Assistant Professor Department of Pharmacology E mail: [email protected] Overview Drug(Ligand) + Receptor ⇋ Drug-receptor complex Biologic effect “A drug doesn’t work unless it is bound” Drugs only modify underlying biochemical and physiological processes, they do not create effects de novo (anew) Topics of Discussion • DRUG RECEPTOR INTERACTION • DRUG DOSE-RESPONSE RELATIONSHIP • THERAPEUTIC INDEX Drug Mechanisms (How Drugs Act?) Receptor mechanisms: Most drugs exert their effects by binding to receptors This has the effect of either mimicking the body’s own (endogenous) substances binding to receptors or preventing their binding or actions II. Non-receptor mechanisms: These include: 1. 2. 3. 4. 5. 6. Changing Cell Membrane Permeability (Ion Channels) Actions on enzymes Carrier Molecules, e.g. uptake proteins Changing Physical Properties Combining with Other Chemicals Anti-metabolites I. Receptor Mechanisms Drugs typically exert their effects by interacting with a receptor Chemical bonds Electrostatic Hydrogen bond Van der Waals Binding Receptor selective Requires exact fit Usually reversible + Types of receptor-effector linkage: E, enzyme; G, G-protein; R, receptor. Major Receptor Families Ligand-Gated Ion Channels 1. Regulation of flow of ions across cell membranes Depolarization/Hyperpolarization of membrane Associated with receptors for fast neurotransmitters Nicotic receptor - Na+ Major Receptor Families 2. G-Protein coupled receptors – Largest family 3 components 7 membrane-spanning α helices G protein – α subunit - GTPase & βγ cAMP / IP3/ Phospholipase A2/ ion Ch Four Steps Ligand binding G protein activation (cytoplasmic side) Activity of effector (ion channel or enzyme) changed Intracellular second messenger concentration changes cAMP: effector enzyme -- adenylyl cyclase, converting ATP to cAMP – phosphorylates proteins G-Protein Coupled Receptor Major Receptor Families 3. Kinase-linked receptors Cytosolic enzyme activity as integral structure or function Most common tyrosine kinase activity (Kinase = Phosphate) Addition of phosphate changes 3D structure of protein Insulin Major Receptor Families 4. Nuclear receptors TWO main categories Those present in cytoplasm form complex with ligand – migrate to the nucleus eg. Steroid hormones Present in nucleus – ligands usually lipids Binds to specific DNA sequences resulting in regulating gene sequences – protein synthesis Longer time course of action Responsible for 10% of pharmacology and the pharmacokinetics of 60% of all prescription drugs Topics of Discussion • DRUG RECEPTOR INTERACTION • DRUG DOSE-RESPONSE RELATIONSHIP • THERAPEUTIC INDEX Drug Dose-Response Relationship Graded dose-response relations Drug-Receptor binding Relationship of binding to effect Potency Efficacy Nature of interactions Agonists Antagonists Functional antagonism Partial agonists Drug-receptor Binding Effect of dose on the magnitude of drug binding Relationship of binding to effect assumes Magnitude proportional to receptors bound Maximum efficacy when all receptors bound Binding does not show cooperation Interactive Pharmacology II. Non-receptor Mechanisms 1. Actions on Enzymes Enzymes = Biological catalysts Speed chemical reactions Are not changed themselves Some drugs alter enzyme activity & alter processes catalyzed by the enzymes Examples Cholinesterase inhibitors Monoamine oxidase inhibitors 2. Interacting With Carrier/Transporter Proteins Example: Maprotiline inhibits NE carrier blocks re-uptake of NE and increase its concentrations at the synapse 3. Changing Physical Properties Example: Mannitol Changes osmotic balance across membranes Causes urine production (osmotic diuresis) Non-receptor Mechanisms, contd. 4. Changing Cell Membrane Permeability (Ion Channels) Lidocaine (a local anesthetic) decreases permeability of the nerve cell membrane to NA+ the rate of depolarization of the nerve membrane, threshold for electrical excitability, & propagation of the action potential Verapamil & nefedipine (calcium channel blockers) Block calcium channels Ca influx into smooth and cardiac muscle vasodialate vascular smooth muscle & myocardial contractility, slow AV nodal conduction Adenosine (an inhibitory neurotransmitter) Opens potassium channels 5. Combining with Other Chemicals Examples Antacids Chelating toxicity agents (e.g., dimercaprol) that bind heavy metals, and thus reduce their Non-receptor Mechanisms, contd. 6. Anti-metabolites An anti-metabolite is a chemical with a similar structure to a substance (a metabolite) required for normal biochemical reactions, yet different enough to interfere with the normal functions of cells, including cell division Examples: Anti-neoplastics e.g., 5-FU (5-fluorouracil) inhibits RNA synthesis Antimicrobials such as sulfonamide drugs, which inhibit dihydrofolate synthesis in bacteria by competing with para-aminobenzoic acid Potency Graded dose-response curve shows potency Determine Effective Concentration 50% EC50 ED50: The dose or concentration required to produce 50% of the maximal effect 50% Efficacy Efficiency is dependent on number of drug-receptor complexes formed and corresponding cellular response A drug with more efficacy is better than drug with more potency Nature of Interactions Agonist If a drug binds to a receptor and produces a biologic response that mimics the response to the endogenous ligand Partial agonist Has intrinsic activity less than that of a full agonist Theoretical occupancy and response curves for full vs partial agonists The occupancy curve is for both drugs, the response curves a and b are for full and partial agonist, respectively. The relationship between response and occupancy for full and partial agonist, corresponding to the response curves in A. Note that curve a produces maximal response at about 20% occupancy, while curve b produces only a submaximal response even at 100% occupancy. Nature of Interactions Antagonist Drugs that decrease the actions of the endogenous ligand. Reversible vs Irreversible Functional antagonism (physiologic antagonism) Antagonist binds completely separate receptor initiating effects functionally opposite of the agonist Epinephine binding to (β2 adrenergic receptor ) reversing Histamine-induced bronchoconstriction (H1 receptor) Reversible vs irreversible competitive antagonists A. Reversible competitive antagonism – log concentration-effect curve shifts to right without change in slope maximum B. Irreversible competitive antagonism – Covalent bond formed with receptor eg. Aspirin & Omeprazole 1 = 50% occupancy Body adapts to drugs Change in receptors Refractory period after effect of first dose - Desensitisation Loss or addition of receptors Internalization of receptors due to prolonged exposure to agonist – and converse. Exhaustion of mediators Amphetamine release cathecholamine – stores depleted Increased metabolic degradation of drug Tolerance Physiological adaptation Topics of Discussion • DRUG RECEPTOR INTERACTION • DRUG DOSE-RESPONSE RELATIONSHIP • THERAPEUTIC INDEX Therapeutic Index Therapeutic index is the ratio of the dose that produces toxicity : dose for clinically desired effective response (50% o f population) Therapeutic Index = TD50/ ED50 Therapeutic Index (T.I.), contd. High therapeutic index NSAIDs Aspirin Tylenol Ibuprofen Most antibiotics Beta-blockers Low therapeutic index Lithium Neuroleptics Phenytoin Phenobarbital Digoxin Immunosuppressives Summary Drugs only modify underlying biochemical and physiological processes, they do not create effects de novo (anew) 4 ways drugs and receptors interact Dose-Response Curve Potency vs Efficacy 4 Nature of Interactions Body adapts to drug Therapeutic Index References Howland et al (2006) Lippincott’s Pharmacology 3rd Ed. Rang et al (2007) Rang & Dale’s Pharmacology 6th Ed.